MedPath

Sleep Matters Trial

Completed
Conditions
We are studying the relation between insomnia symptoms and dissociative symptoms.
Mental and Behavioural Disorders
Registration Number
ISRCTN58986139
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
85
Inclusion Criteria

1. Participant is willing and able to give informed consent for participation in the study.
2. Symptoms of insomnia, as indicated by the SCI
3. Medium-to-high level of dissociativity, as indicated by a score of 17 or more on the DES
4. Age >= 18 years (no upper limit), any gender

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To test whether delivering digital CBTi improves insomnia symptoms. Outcome measure is the Sleep Condition Indicator, administered before, during, and after the intervention<br>2. To test whether sleep improvement (through digital CBTi) can reduce dissociative symptoms. Outcome measures are the Dissociative Experiences Scale, and the Clinician-Administered Dissociative States Scale, administered before, during, and after the intervention
Secondary Outcome Measures
NameTimeMethod
1. To determine whether digital CBTi improves negative affect: depression, anxiety, and stress. Outcome measures are the Depression Anxiety Stress Scales (DASS) to measure depression, anxiety, and stress administered before, during, and after the intervention<br>2. To determine whether changes in anxiety symptoms mediate changes in dissociative symptoms. Current statistical techniques for mediation will be employed, using the primary outcome measures at all time points
© Copyright 2025. All Rights Reserved by MedPath